Abbott Laboratories (ABT) Tops Q1 EPS by 5c; Reaffirms FY14 Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $90.52 -0.01%
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q1 ongoing EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $5.24 billion versus the consensus estimate of $5.29 billion.
Abbott reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- FedEx (FDX) PT Lowered to $397 at Bernstein SocGen Group
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
